Label: CLARITIN- loratadine tablet

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated December 28, 2025

If you are a consumer or patient please visit this version.

View All Sections
  • SPL UNCLASSIFIED SECTION

    Drug Facts

  • SPL UNCLASSIFIED SECTION

  • ACTIVE INGREDIENT

    Active ingredient (in each tablet)

    Loratadine, 10 mg USP

  • PURPOSE

    Purpose

    Antihistamine

  • Uses

    Temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

    ■ runny nose ■ sneezing

    ■ itchy, watery eyes ■ itching of the nose or throat

  • Warnings

    Do not useif you have ever had an allergic reaction to this product or any of its ingredients.

    Ask a doctor

    Ask a doctor before use if you haveliver or kidney disease. Your doctor should determine if you need a different dose.

    When using this product

    When using this productdo not take more than directed. Taking more than directed may cause drowsiness.

    Stop use

    Stop use and ask a doctor ifan allergic reaction to this product occurs. Seek medical help right away.

    If pregnant or breast-feeding

    If pregnant or breast-feeding, ask a health professional before use.

    Keep out of reach of children

    Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

  • Directions

    Directions

    adults and children 6 years and over1 tablet daily; not more than 1 tablet in 24 hours
    children under 6 years of ageask a doctor
    consumers with liver or kidney diseaseask a doctor

  • Other information

    ■ store at 20º -25º C (68º -77º F) (see USP Controlled Room Temperature)

  • INACTIVE INGREDIENT

    Inactive ingredientslactose monohydrate, magnesium stearate, microcrystalline cellulose, sodium starch glycolate

  • QUESTIONS

    Questions or comments?

    1-800-CLARITIN (1-800-252-7484) or www.claritin.com

  • Claritin 1 pouch

    claritin1

  • PRINCIPAL DISPLAY PANEL

    claritin20

  • claritin 25

    claritin25

  • INGREDIENTS AND APPEARANCE
    CLARITIN 
    loratadine tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:85237-1630(NDC:11523-0800)
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    LORATADINE (UNII: 7AJO3BO7QN) (LORATADINE - UNII:7AJO3BO7QN) LORATADINE10 mg
    Inactive Ingredients
    Ingredient NameStrength
    LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    SODIUM STARCH GLYCOLATE TYPE A CORN (UNII: AG9B65PV6B)  
    Product Characteristics
    ColorwhiteScoreno score
    ShapeROUNDSize10mm
    FlavorImprint Code Claritin;10;458
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:85237-1630-11 in 1 CARTON08/18/2025
    11 in 1 BLISTER PACK; Type 0: Not a Combination Product
    2NDC:85237-1630-320 in 1 BOX, UNIT-DOSE12/27/2025
    21 in 1 POUCH; Type 0: Not a Combination Product
    3NDC:85237-1630-425 in 1 BOX, UNIT-DOSE12/27/2025
    31 in 1 POUCH; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA07520912/01/2020
    Labeler - Select Consumer Group (119185084)
    Establishment
    NameAddressID/FEIBusiness Operations
    Select Consumer Group119185084repack(85237-1630)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!